Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The first two patients have been registered to the IMAGO study (Chief Investigator: Dr Simon Lord), a single arm exploratory study examining the feasibility of imaging glioblastoma pH using CEST-MRI. The study is managed by OCTO (Oncology Clinical Trials Office) and sponsored by the University of Oxford.